Page URL:

Mutations identified for severe developmental disease found among Moroccan Jews

17 March 2014
Appeared in BioNews 746

Researchers have pinpointed two genetic mutations behind a severe developmental disease seen in children of Moroccan Jewish descent.

Scientists at Ben-Gurion University of the Negev, Israel, studied ten patients from four families that have PCCA2 (Progressive Cerebello-Cerebral Atrophy Type 2).

Children who have the disease appear normal at birth and develop as expected until about six months. However, by one year, patients develop brain atrophy (a loss of brain cells), mental retardation and epilepsy. At three years old, most patients will be in a near-vegetative state.

The work to find the gene behind the condition was led by Professor Ohad Birk and Miora Feinstein, a doctoral student. They found that the disease is caused by two different mutations in the same gene - VPS53.

The exact reasons why VPS53 mutations cause PCCA2 are unclear. However, the researchers that the tiny pockets that carry material around cells, called endosomes, do not move around like they should. As a result, waste material, which should be broken down and destroyed, builds up within the cell.

Professor Birk's group has now discovered more than 20 genetic diseases found in people of Arab and Sephardi Jewish backgrounds. In 2010, they identified mutations in a gene called SESPSECS, which prevent the mineral selenium from being used in the body and cause a very similar disease called PCCA.

'There was an idea that Ashkenazi Jews have more disease than others, but when one begins looking at Sephardic Jewish diseases, they are there', Professor Birk said.

'They have just not been sorted out. Because they have not been sorted out, there was no carrier testing, no prevention programmes or anything. I have shifted part of my lab into this, into Jewish non-Ashkenazi - or Sephardic Jewish - diseases'.

PCCA2 is a recessive disease, meaning that both parents must be carriers of a VPS53 mutation. Children have a 25 percent risk of inheriting two mutated copies of VPS53, and having the disease.

As one in 37 Moroccan Jews carry VPS53 mutations, PCCA2 is now the most common severe genetic disease in this community.

Fifteen percent of Israel's population (one million people) is of Moroccan ancestry. Nearly 100,000 Moroccan Jews also live in the USA, meaning a large number of people are at risk of inheriting the disease.

Carrier testing for SESPSECS mutations was introduced in 2011 for all Jews of Moroccan or Iraqi ancestry. Now researchers have called for routine carrier screening for VSP53 mutations as well. This might even start within the year, and could help reduce the number of people inheriting the disease.

The study was published in the the Journal of Medical Genetics.

20 April 2015 - by Chris Baldacci 
Geneticists have estimated that each of us carries an average of one or two lethal, but recessive, genes in our DNA...
25 November 2013 - by Dr Lucy Freem 
A strategy to improve diagnosis, research, and treatment of rare diseases has been launched by the UK Government...
28 October 2013 - by Dr Lucy Freem 
A three-year joint project to sequence the genomes of 10,000 rare disease patients has been announced by the University of Cambridge, Genomics England and Illumina...
13 May 2013 - by Dr Linda Wijlaars 
A genetic mutation responsible for both Sturge-Weber syndrome, a rare neurological disorder, and 'port-wine stain' birthmarks, has been identified...
18 March 2013 - by Antony Starza-Allen 
A genetic mutation linked to mental retardation has been identified in an Amish community in the USA....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.